AtriCure (ATRC) announced that the first patient was enrolled and treated in the BoxX-NoAF clinical trial. The first patient was treated at Orlando Health Heart and Vascular Institute in Orlando, Florida.
Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on ATRC:
- AtriCure’s Ongoing Study: Implications for Cardiac Treatment and Market Performance
- AtriCure’s Cryoablation Study: A New Frontier in Pain Management
- AtriCure’s TRAC-AF Registry: A Closer Look at Ongoing Clinical Study
- AtriCure’s BoxX-NoAF Trial: A Step Forward in Cardiac Surgery Innovation
- AtriCure’s HEAL-IST IDE Trial: A Promising Step in Treating Inappropriate Sinus Tachycardia